Epidemiological evaluation of canine epilepsy is an under-researched area. The objectives of this study were to estimate prevalence and investigate risk factors for epilepsy of unknown origin (EUO) among dogs attending primary veterinary practices in the UK. The clinical data analysed spanned a two-year period and included all dogs attending 92 primary veterinary clinics participating in the VetCompass project. Five hundred and thirty-nine EUO cases were identified giving a prevalence of 0.62% (95% CI 0.57% to 0.67%). Males were over 1.5 times as likely to have EUO compared with females (95% CI 1.44 to 2.06; P<0.001). Of purebred dogs, the border terrier had 2.70 (95% CI 1.57 to 4.62; P<0.001) and the German shepherd dog had 1.90 (95% CI 1.28 to 2.80; P=0.001) times increased odds of EUO compared with crossbred dogs. In addition, the West Highland white terrier had reduced odds (OR 0.23; 95% CI 0.08 to 0.62; P=0.004) of EUO compared with crossbred dogs (likelihood ratio test P<0.0001). No association was found with neuter status, colour or weight. The current study highlights the clinical importance of epilepsy as a canine disorder in the UK. Increased awareness of sex and breed predispositions may assist clinicians with diagnosis. Further research is merited to evaluate the specific breed associations identified.
Introduction
Epilepsy is the most common chronic neurological disorder in human beings with an estimated worldwide incidence of approximately 0.05-0.1 per cent, and a prevalence of 0.4-1 per cent (Sander and Shorvon 1996, Cowan 2002) . Epilepsy in dogs has also been suggested to be the most common chronic neurological condition (Chandler 2006, Fluehmann and others 2006) with an estimated prevalence of 1-2 per cent in a referral hospital population (Schwartz-Porsche 1986) . The exact prevalence of epilepsy in the general dog population, however, remains unknown.
Recently, individual breed and country-specific prevalence of canine genetic epilepsy have been estimated ranging from 0.7 per cent to 18.3 per cent (Jaggy and others 1998 , Kathmann and others 1999 , Berendt and others 2002 , Casal and others 2006 , Gullov and others 2011 . Despite reports showing a higher risk of epilepsy in certain breeds, there remains a lack of epidemiological studies estimating prevalence and investigating risk factors for epilepsy in general dog populations. Short and others (2011) have investigated associations between sex and neuter status with treated cases of epilepsy, but did not statistically evaluate breed effects. Idiopathic epilepsy (IE) has also been seen more frequently in solid coat-colour Cavalier King Charles spaniels indicating that the number of colours may have some association with the disease (Rusbridge 2005) . The current study aimed to investigate the prevalence and risk factors for canine epilepsy of unknown origin (EUO) in the UK in general practice in order to better understand the clinical importance of the disorder.
Materials and methods
Study data were collected within VetCompass Animal Surveillance (Vetcompass 2011), an ongoing Royal Veterinary College (RVC) project sharing first-opinion clinical data with UK veterinary practices via Practice Management Systems (PMSs). Participating practices routinely recorded electronic patient records and, additionally, selected the most appropriate summary diagnostic terms from an embedded list of standard terminology, the VeNom codes (Venom Coding Group 2011), at the end of each episode of clinical care. Data were uploaded from the PMSs of participating practices to the VetCompass database. Ethics approval was obtained from the RVC Ethics and Welfare Committee (URN 20101076a).
The diagnosis of EUO was based on a history of more than two seizures in the absence of other medical problems and a history of seizures for more than one year, or four or more separate repeat antiepileptic drug prescriptions (in the absence of evidence of their use for any purpose other than seizure control). Absence of other medical problems was confirmed for all affected dogs by unremarkable clinical examination results, complete blood count and serum biochemical analysis. Identified patients were excluded if the records reported evidence of an underlying disease that could have caused epilepsy, including advanced brain imaging abnormalities, or there was insufficient information on the chronicity of the disease.
All purebred names and groups were established using the Kennel Club (KC) database (UK Kennel Club 2011) . Values from the earliest consultation with a diagnosis of EUO were used for weight, while values from the earliest overall observation were included for non-EUO cases. Age and neuter status were taken from the last record Veterinary Record (2013) doi: 10.1136/vr.101133
of each dog. The risk factors investigated were sex, neuter status, breed, purebred status, purebred KC group, purebred KC size category, purebred KC coat length, coat-colour and weight with age included as a potential confounder.
Data analysis
Data were imported into Microsoft Excel I for cleaning before being analysed using the statistical software Stata II . Data cleaning included data entry checks, standardisation of breed and other factors and consolidation of the data into one unique record per dog. Descriptive statistics were generated for the overall population of EUO dogs. Univariable risk factor analysis was performed on all variables to evaluate an association with EUO with χ 2 and Fisher's exact tests for categorical, and the unpaired t test and Mann-Whitney U test for continuous data, respectively. Mixed-effects logistic regression models using the 'xtmelogit' command were constructed accounting for clustering at the veterinary clinic level. Risk factors with a liberal univariable association with the outcome (P<0.15) were carried forward for multivariable analysis (Dohoo and others 2010) . Model building followed a manual forward stepwise construction process using the likelihood ratio test. Final model variables were assessed for pairwise interactions. The 'quadchk' command was performed to assess clinic as a random effect, and the final model fit was evaluated with the Hosmer-Lemeshow goodness-of-fit test. Statistical significance was set at the 5 per cent level.
Results
Ninety-two UK veterinary practices contributed data relating to 87,317 dogs with a total of 680,322 observations between January 2010 and April 2011. Forty-eight percent of all dogs were female (95% CI 47.3% to 48.0%), 53.0% (95% CI 52.7% to 53.4%) were neutered and 20.1% (95% CI 19.8% to 20.4%) were crossbreds. The most common dog breeds were the labrador retriever (9.8 per cent), Staffordshire bull terrier (7.8 per cent), Parsons (Jack) Russell terrier (7.1 per cent) and cocker spaniel (4.0 per cent). The most common KC breed groups were the terrier group (22.2 per cent), gundogs (21.4 per cent), toy group (10.7 per cent) and pastoral (8.5 per cent). Of KC purebreds, 20.2 per cent and 27.4 per cent were small and large-sized, respectively, and 44.2 per cent and 7.4 per cent were short and long-haired. Many (42.6 per cent) of the dogs were solid coat-colour; 11.6 per cent were black and 11.4 per cent were red-golden, while 37.4 per cent of dogs were two-tone in colour and 19.9 per cent were multicoloured. Of the 99.5 per cent of dogs with age data, 38.3 per cent of dogs were older than six years at the final record available.
Five hundred and thirty-nine cases met the inclusion criteria, giving an EUO prevalence of 0.62% (95% CI 0.57% to 0.67%). Overall among cases, 2.2 per cent had undergone an MRI scan and 87.8 per cent received long-term antiepileptic medication. The majority of EUO dogs on treatment were prescribed monotherapy during the study period (83.7 per cent), though 15.4 per cent received two and 0.9 per cent received three or more therapies (Table 1) . Phenobarbitone was the major drug prescribed, with approximately 96 per cent of EUO dogs receiving it, while potassium bromide, either prescribed on its own or with phenobarbitone, was prescribed for 18 per cent of cases.
Analysis of risk factors
Univariable risk factor analysis identified males, and neutered dogs appeared at increased odds of EUO (Table 2) . Individual breeds also appeared at increased odds of EUO, though purebred dogs (as a group) versus crossbred dogs were not statistically significant in the univariable analysis. Heavier dogs were statistically significantly associated with presence of EUO, as were short coat length and certain coat colours in purebred dogs.
In the multivariable analysis, sex, breed and age at consultation were statistically significantly associated with presence of EUO ( No final model pairwise interactions were detected, and clinic attended was retained in the final model as a random effect (P=0.0017). The Hosmer-Lemeshow test suggested good model fit (P=0.8552). (Jaggy and others 1998 , Kathmann and others 1999 , Berendt and others 2002 , Casal and others 2006 , Gullov and others 2011 . This retrospective study identifies EUO as an important disorder among dogs with a clinically relevant prevalence of 0.62 per cent. The study highlights sex and breed as a major risk factors for the disorder. Consistent with previous work, male dogs were at increased odds of having the condition. German shepherd dogs and border terriers were identified as associated with increased odds of the condition, while West Highland white terriers showed reduced odds of EUO.
Discussion
Previous work has reported a wide range of prevalence of IE of between 0.7 per cent and 18 per cent (Jaggy and others 1998 , Kathmann and others 1999 , Berendt and others 2002 , Casal and others 2006 , Gullov and others 2011 . These studies related to individual breeds and specific countries, and the current work suggests the prevalence in the UK veterinary primary practice attending population is likely to be at the lower end of this range. The treatments administered were consistent with previous work in the UK (Short and others 2011) , with phenobarbitone representing the major drug used for therapy. Interestingly, a small but still clinically relevant number of dogs were additionally or solely treated with potassium bromide, suggesting that for a number of dogs, phenobarbitone therapy did not appear to adequately control the seizures.
The finding that male dogs were at increased odds of EUO compared with female dogs is consistent with previous epidemiological work on IE from Short and others (2011) (OR 1.64; 95% CI 1.42 to 1.89). Several breed-specific studies have also reported an over-representation of male dogs (Bielfelt and others 1971 , Srenk and others 1994 , Kathmann and others 1999 , Patterson and others 2005 , Casal and others 2006 , Gullov and others 2011 . It has been suggested that IE is an autosomal recessive trait, according to the results of a study by Casal and others (2006) , with a tendency for increased risk in male dogs, though this work relates to one breed only, and hence, the genetic basis may be of limited relevance to the wider canine population.
In the current study, neuter status was not shown to be associated with EUO, in agreement with several studies others 2002, 2008) , but contradicting the findings of Short and others (2011) (OR 1.59; 95% CI 1.37 to 1.85). Short and others (2011) speculated that their findings might have been biased by reverse causality where dogs with epilepsy were then neutered due to the belief that neutering improved seizure control. The lack of an association between neuter- ing and EUO in the current study suggests any biological association may be minor.
Though purebred dogs per se did not appear at increased odds of EUO compared with crossbreds, the current study identified specific individual breeds at increased odds of the disease. This is consistent with previous work evaluating breed associations with IE (Chandler 2006, Seppala and others 2012) . This study reinforces evidence for an increased risk of EUO in the German shepherd dog (Falco and others 1974) and border terrier (Kloene and others 2008) . Increased odds of EUO in certain purebred dogs may result from decreasing genetic diversity resulting from selective breeding used to maintain purebred characteristics. Interestingly, the West Highland white terrier was associated with reduced odds of EUO. This has not previously been reported. To date, most studies of canine IE have related to specific dog breeds with poor generalisation to the wider dog population.
In a recent study of canine epilepsy in the UK, Short and others (2011) suggested that the border collie and Staffordshire bull terrier were at greater risk of developing epilepsy by comparing epilepsy cases with annual registration figures with the KC. The cross-sectional nature of their study and the inclusion of only treated epileptic dogs compared with laboratory-based controls derived from a genetic database meant it may have been prone to selection bias (Short and others 2011). The current investigation aimed to reduce selection bias by ensuring that both cases and non-cases were representative of the target population. The study sampled the entire vet-visiting population that included over 87,000 dogs from 92 veterinary clinics in the UK, and all dogs with data recorded were included. There were some limitations to this study. The study dataset included both pre-existing and incident cases, reducing the value of age at consultation as a predictive factor. The age values used in the analysis related to the final age recorded in the dataset which, while consistent between case and non-case dogs, gave no indication of age of onset. Age was included in the model primarily to control for its potential confounding effect rather than to generate information on age as a risk factor. A cohort of longer duration would be required to investigate the age at first diagnosis of EUO in incident cases. Case identification relied strongly on veterinarian clinical acumen and diagnostic resources. Some EUO cases may have been missed due to unusual, mild or infrequent clinical signs leading to underreporting. Additionally, due to limited financial and clinical resources, it is possible that some cases of EUO were incorrectly diagnosed as such due to an inability to undertake more in-depth diagnostic procedures to identify underlying primary disease. Among the 539 cases in this study, just 2.2 per cent were noted to have received an MRI examination in the study period, and only 0.9 per cent of EUO dogs aged over six years underwent an MRI examination. It is possible that some of the older dogs could have had undetected intracranial pathology. In a recent study of dogs with epilepsy, only 2.2 per cent of dogs with a normal interictal neurological exam had brain changes visible on MRI when they were less than six years of age, whereas 26.7 per cent had abnormal MRI findings when older than six years of age (Smith and others 2008) . However, it is possible that the level of MRI examination was underestimated in the current study because some dogs could have had an MRI prior to the study period that was not noted in the records. Nonetheless, despite the potential for misclassification of disease, this remains a valuable estimate of the prevalence of EUO in a broad, first-opinion, veterinary practice population.
Mixed-effects modelling accounted for the clustering effects of veterinary clinic within the data as it was likely there might be variation between clinics in the diagnosis and treatment of the disease. Multivariable modelling adjusted for known measurable confounders, in particular, age at consultation. However, there may have been other confounding variables to consider. Insurance status of the dog may impact on the likelihood of a diagnosis of EUO (Egenvall and others 2009). Insured dogs may be more thoroughly worked up because financial constraints are less limiting. Owner socioeconomic status may also confound the outcome. In human beings, there is evidence of association between socioeconomical status and hospitalisation for epilepsy (Li and others 2008) . Postcode data (available with the VetCompass dataset) could be used to explore an association between an owner's socioeconomic status and EUO in future studies. In addition, ArcGIS mapping could be performed with these postcodes to investigate evidence for case clustering. History of another dog or family member with epilepsy may also be a confounder, as past events may influence present decisions on further treatment, investigation or euthanasia.
Conclusion
This large retrospective study describes an epidemiological approach to the study of prevalence and risk factors for EUO among dogs in the UK. In this study, EUO prevalence was found to be 0.62 per cent. Risk factors associated with EUO included sex and breed, with strong evidence that male dogs were at increased odds of EUO compared with female dogs. The current study reinforces evidence for association between the German shepherd dog and border terrier breeds with EUO, and highlights a previously unreported finding of a reduced odds of EUO in West Highland white terriers. While certain breeds appeared at increased odds of EUO, overall purebred dogs, in general, were not found to be at a greater odds of the disease compared with crossbred dogs. A cohort of longer duration is needed to assess incident cases and progression of the disease, while repeat analysis of the expanding VetCompass dataset would increase power to evaluate other breed effects. group.bmj.com on January 9, 2013 -Published by veterinaryrecord.bmj.com Downloaded from
